Security Snapshot

Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) Institutional Ownership

CUSIP: 81728J109

13F Institutional Holders and Ownership History from Q3 2016 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

38

Shares (Excl. Options)

3,647,794

Price

$3.02

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-285,957
Value change
-$1,026,991
Number of holders
38
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
16,385,263
SEC-reported price per share
$2.85
Insider filing price
$2.85
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 81728J109.
  • 38 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 40 to 38 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $15,719,197 to $11,024,452.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 38 institutions filings for Q2 2026.

Open SEC evidence

Security key

81728J109

Latest holder period

Q2 2026

13F holders

38

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
SRTS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Solot Edwin Lee 7.6% $5,827,910 1,245,280 Edwin L. Solot, Jr. 31 Dec 2024

As of 30 Jun 2026, 38 institutional investors reported holding 3,647,794 shares of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS). This represents 22% of the company’s total 16,385,263 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
22%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Pacific Ridge Capital Partners, LLC 4.8% 789,675 -0.8% 0.43% $2,384,819
VANGUARD CAPITAL MANAGEMENT LLC 4% 660,402 +1.9% 0% $1,994,414
DIMENSIONAL FUND ADVISORS LP 1.9% 316,121 -18% 0% $954,758
Divisadero Street Capital Management, LP 1.7% 278,485 -2.7% 0.02% $841,025
RENAISSANCE TECHNOLOGIES LLC 1.5% 242,334 -3.9% 0% $731,849
GEODE CAPITAL MANAGEMENT, LLC 0.94% 154,152 -6.9% 0% $465,656
UBS Group AG 0.93% 152,573 -12% 0% $460,770
Sachetta, LLC 0.93% 152,008 +1% 0.22% $459,066
Greenline Wealth Management LLC 0.79% 128,774 0% 0.32% $388,897
North Star Investment Management Corp. 0.77% 125,586 0% 0.02% $379,270
Bank of New York Mellon Corp 0.61% 100,410 0% 0% $303,239
BlackRock, Inc. 0.51% 83,555 +17% 0% $252,336
VANGUARD FIDUCIARY TRUST CO 0.47% 76,289 +0.74% 0% $230,393
STATE STREET CORP 0.42% 69,252 0% 0% $209,141
INGALLS & SNYDER LLC 0.34% 55,000 0% 0% $166,000
MINDSET WEALTH MANAGEMENT, LLC 0.32% 52,100 0% 0.03% $157,342
Janney Montgomery Scott LLC 0.25% 40,576 0% 0% $123,000
NORTHERN TRUST CORP 0.17% 28,187 -59% 0% $85,125
CHAPIN DAVIS, INC. 0.16% 26,000 0% 0.01% $78,520
AMERICAN CENTURY COMPANIES INC 0.13% 21,272 0% 0% $64,241
Ashton Thomas Private Wealth, LLC 0.1% 16,307 +4.1% 0% $49,247
EP Wealth Advisors, LLC 0.1% 16,065 0% $48,516
StoneX Group Inc. 0.08% 13,378 0% $47,938
JANE STREET GROUP, LLC 0.08% 12,518 -44% 0% $37,804
XTX Topco Ltd 0.07% 12,178 0% $36,778

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
40
Latest
Q2 2026
Rows shown
1-25 of 40
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 3,647,794 $11,024,452 -$1,026,991 $3.02 38
2026 Q1 3,949,816 $15,719,197 -$422,947 $3.98 40
2025 Q4 4,180,766 $16,643,426 -$595,599 $3.98 45
2025 Q3 4,213,544 $13,235,817 -$716,846 $3.14 42
2025 Q2 4,345,464 $20,596,029 +$1,512,062 $4.74 46
2025 Q1 4,026,834 $19,046,437 -$6,276,532 $4.73 53
2024 Q4 4,903,533 $33,920,348 +$6,954,088 $6.92 65
2024 Q3 3,885,568 $22,593,506 +$3,373,159 $5.80 50
2024 Q2 3,273,489 $17,552,838 +$4,434,599 $5.33 47
2024 Q1 2,481,212 $9,277,180 -$140,014 $3.80 45
2023 Q4 2,617,403 $6,188,682 -$467,743 $2.36 40
2023 Q3 2,661,310 $7,368,535 -$2,226,146 $2.77 40
2023 Q2 3,414,591 $10,755,535 -$7,918,322 $3.15 49
2023 Q1 4,900,010 $25,524,883 -$1,697,795 $5.21 66
2022 Q4 5,076,199 $37,640,159 -$13,766,550 $7.42 66
2022 Q3 6,115,199 $76,605,789 +$14,256,431 $12.53 77
2022 Q2 5,091,341 $39,116,200 +$6,033,503 $7.68 56
2022 Q1 4,419,085 $44,720,750 +$21,822,621 $10.12 53
2021 Q4 2,277,916 $16,438,000 +$8,095,278 $7.22 37
2021 Q3 1,309,389 $4,714,000 +$14,842 $3.60 18
2021 Q2 1,302,714 $5,014,000 -$279,059 $3.85 18
2021 Q1 1,376,215 $5,267,000 +$241,320 $3.82 20
2020 Q4 1,312,808 $5,067,000 +$189,276 $3.86 17
2020 Q3 1,267,945 $3,195,000 -$285,048 $2.52 20
2020 Q2 1,140,216 $3,499,000 -$583,507 $3.06 17
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .